MKI67 and neoplasm: However, although compelling preclinical data suggest that an increased physical activity level reduces tumor growth, establishing a therapeutic effect of increased physical activity level in vivo in humans has proven challenging because of the limited specificity of indirect biomarkers of tumor growth (e.g., prostate-specific antigen, Ki67) and the difficulty in accurately assessing tumor growth over prolonged intervention periods (19–21).